Literature DB >> 22886062

Tract-specific quantitative MRI better correlates with disability than conventional MRI in multiple sclerosis.

Daniel M Harrison1, Navid Shiee, Pierre-Louis Bazin, Scott D Newsome, John N Ratchford, Dzung Pham, Peter A Calabresi, Daniel S Reich.   

Abstract

Although diffusion tensor imaging (DTI) and the magnetization transfer ratio (MTR) have been extensively studied in multiple sclerosis (MS), it is still unclear if they are more effective biomarkers of disability than conventional MRI. MRI scans were performed on 117 participants with MS in addition to 26 healthy volunteers. Mean values were obtained for DTI indices and MTR for supratentorial brain and three white matter tracts of interest. DTI and MTR values were tested for correlations with measures of atrophy and lesion volume and were compared with these more conventional indices for prediction of disability. All DTI and MTR values correlated to an equivalent degree with lesion volume and cerebral volume fraction (CVF). Thalamic volumes correlated with all indices in the optic radiations and with mean and perpendicular diffusivity in the corpus callosum. Nested model regression analysis demonstrated that, compared with CVF, DTI indices in the optic radiations were more strongly correlated with Expanded Disability Status Scale and were also more strongly correlated than both CVF and lesion volume with low-contrast visual acuity. Abnormalities in DTI and MTR are equivalently linked with brain atrophy and inflammatory lesion burden, suggesting that for practical purposes they are markers of multiple aspects of MS pathology. Our findings that some DTI and MTR indices are more strongly linked with disability than conventional MRI measures justifies their potential use as targeted, functional system-specific clinical trial outcomes in MS.

Entities:  

Mesh:

Year:  2012        PMID: 22886062      PMCID: PMC3753185          DOI: 10.1007/s00415-012-6638-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  35 in total

Review 1.  The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force.

Authors:  J S Fischer; R A Rudick; G R Cutter; S C Reingold
Journal:  Mult Scler       Date:  1999-08       Impact factor: 6.312

2.  Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force.

Authors:  R Rudick; J Antel; C Confavreux; G Cutter; G Ellison; J Fischer; F Lublin; A Miller; J Petkau; S Rao; S Reingold; K Syndulko; A Thompson; J Wallenberg; B Weinshenker; E Willoughby
Journal:  Ann Neurol       Date:  1997-09       Impact factor: 10.422

3.  Development of a multiple sclerosis functional composite as a clinical trial outcome measure.

Authors:  G R Cutter; M L Baier; R A Rudick; D L Cookfair; J S Fischer; J Petkau; K Syndulko; B G Weinshenker; J P Antel; C Confavreux; G W Ellison; F Lublin; A E Miller; S M Rao; S Reingold; A Thompson; E Willoughby
Journal:  Brain       Date:  1999-05       Impact factor: 13.501

4.  Demyelination increases radial diffusivity in corpus callosum of mouse brain.

Authors:  Sheng-Kwei Song; Jun Yoshino; Tuan Q Le; Shiow-Jiuan Lin; Shu-Wei Sun; Anne H Cross; Regina C Armstrong
Journal:  Neuroimage       Date:  2005-05-15       Impact factor: 6.556

5.  Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis.

Authors:  M L Baier; G R Cutter; R A Rudick; D Miller; J A Cohen; B Weinstock-Guttman; M Mass; L J Balcer
Journal:  Neurology       Date:  2005-03-22       Impact factor: 9.910

6.  Axonal transection in the lesions of multiple sclerosis.

Authors:  B D Trapp; J Peterson; R M Ransohoff; R Rudick; S Mörk; L Bö
Journal:  N Engl J Med       Date:  1998-01-29       Impact factor: 91.245

7.  A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis.

Authors:  M Filippi; A Campi; V Dousset; C Baratti; V Martinelli; N Canal; G Scotti; G Comi
Journal:  Neurology       Date:  1995-03       Impact factor: 9.910

8.  Magnetization transfer ratios of multiple sclerosis lesions with variable durations of enhancement.

Authors:  M Filippi; M A Rocca; G Comi
Journal:  J Neurol Sci       Date:  1998-08-14       Impact factor: 3.181

9.  Axonal injury heralds virus-induced demyelination.

Authors:  Ikuo Tsunoda; Li-Qing Kuang; Jane E Libbey; Robert S Fujinami
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

10.  MR correlates of cerebral atrophy in patients with multiple sclerosis.

Authors:  Nicola De Stefano; Giuseppe Iannucci; Maria P Sormani; Leonello Guidi; Maria L Bartolozzi; Giancarlo Comi; Antonio Federico; Massimo Filippi
Journal:  J Neurol       Date:  2002-08       Impact factor: 4.849

View more
  22 in total

1.  The relationship between corticospinal tract integrity and lower-extremity strength is attenuated when controlling for age and sex in multiple sclerosis.

Authors:  Jessica F Baird; Elizabeth A Hubbard; Bradley P Sutton; Robert W Motl
Journal:  Brain Res       Date:  2018-09-10       Impact factor: 3.252

Review 2.  Tracking cerebral white matter changes across the lifespan: insights from diffusion tensor imaging studies.

Authors:  Qian Jun Yap; Irvin Teh; Paolo Fusar-Poli; Min Yi Sum; Carissa Kuswanto; Kang Sim
Journal:  J Neural Transm (Vienna)       Date:  2013-01-18       Impact factor: 3.575

3.  Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study.

Authors:  Natalia Gonzalez Caldito; Shiv Saidha; Elias S Sotirchos; Blake E Dewey; Norah J Cowley; Jeffrey Glaister; Kathryn C Fitzgerald; Omar Al-Louzi; James Nguyen; Alissa Rothman; Esther Ogbuokiri; Nicholas Fioravante; Sydney Feldman; Ohemaa Kwakyi; Hunter Risher; Dorlan Kimbrough; Teresa C Frohman; Elliot Frohman; Laura Balcer; Ciprian Crainiceanu; Peter C M Van Zijl; Ellen M Mowry; Daniel S Reich; Jiwon Oh; Dzung L Pham; Jerry Prince; Peter A Calabresi
Journal:  Brain       Date:  2018-11-01       Impact factor: 13.501

4.  Monitoring diffuse injury during disease progression in experimental autoimmune encephalomyelitis with on resonance variable delay multiple pulse (onVDMP) CEST MRI.

Authors:  Aline M Thomas; Jiadi Xu; Peter A Calabresi; Peter C M van Zijl; Jeff W M Bulte
Journal:  Neuroimage       Date:  2019-10-09       Impact factor: 6.556

Review 5.  Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives.

Authors:  Daniel Ontaneda; Robert J Fox; Jeremy Chataway
Journal:  Lancet Neurol       Date:  2015-02       Impact factor: 44.182

Review 6.  Multiple sclerosis imaging: recent advances.

Authors:  Maria A Rocca; Roberta Messina; Massimo Filippi
Journal:  J Neurol       Date:  2012-12-21       Impact factor: 4.849

Review 7.  Diffusion tensor imaging for multilevel assessment of the visual pathway: possibilities for personalized outcome prediction in autoimmune disorders of the central nervous system.

Authors:  Joseph Kuchling; Alexander U Brandt; Friedemann Paul; Michael Scheel
Journal:  EPMA J       Date:  2017-07-25       Impact factor: 6.543

8.  Recent imaging advances in neurology.

Authors:  Lorenzo Rocchi; Flavia Niccolini; Marios Politis
Journal:  J Neurol       Date:  2015-03-26       Impact factor: 4.849

9.  Increased brain white matter axial diffusivity associated with fatigue, pain and hyperalgesia in Gulf War illness.

Authors:  Rakib U Rayhan; Benson W Stevens; Christian R Timbol; Oluwatoyin Adewuyi; Brian Walitt; John W VanMeter; James N Baraniuk
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

10.  Axonal loss in major sensorimotor tracts is associated with impaired motor performance in minimally disabled multiple sclerosis patients.

Authors:  Myrte Strik; L Eduardo Cofré Lizama; Camille J Shanahan; Anneke van der Walt; Frederique M C Boonstra; Rebecca Glarin; Trevor J Kilpatrick; Jeroen J G Geurts; Jon O Cleary; Menno M Schoonheim; Mary P Galea; Scott C Kolbe
Journal:  Brain Commun       Date:  2021-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.